Plasminogen Activator Inhibitor (PAI-1), Antigen

Last Modified: 8/31/2023 3:14:41 PM


Medical Necessity Documentation:  
Client Notes:  
Patient Preparation:  
Specimen Requirements:

1.0 mL Plasma from a Blue Top Tube - 3.2% Na Citrate in a Plastic Vial
Collection Instructions: Centrifuge and remove plasma, placing in plastic vial
ReCentrifuge just the plasma and pipette again into another plastic vial
Freeze Immediately (< or = -40° C if possible)
Minimum Volume: 0.3 mL Plasma
Transport & Storage: Temperature/Stability: 14 days Frozen
Rejection Criteria: Ambient; Refrigerated; Gross Hemolysis; Gross Lipemia
Reference Range: Refer to Interpretive Results
Critical Ranges:  
Test Comments:  
Methodology: Enzyme Linked Immunosorbent Immunoassay
Clinical Significance: Increased activity is associated with increased risk of arterial thrombosis, such as with unexplained premature myocardial infarction. As an acute phase reactant, the activity is increased after an acute event. Studies suggest PAI-1 may be a prognostic marker in early stage breast cancer.
Documentation:  
Custom Panel: No

PRODUCTION SCHEDULE

Turn Around Time: 8 to 13 days
Days Performed: Thursday
Sites Performed: Quest - Chantilly to San Juan Capistrano
PHL Test Code: PAI1
EPIC Test Code: LAB1124
Send Out Test Code: 59766 / 36555X
Alternate Test Names: PAI-1; Plasminogen Activator Inhibitor Antigen
Included Tests:  
CPT Coding: 85415

Go back to the top of the page.